Objective  To explore the methods and significance of individualized medication guidance for cardiovascular chronic disease patients under the pharmaceutical informationization construction, and provide references for pharmacists to carry out medication education.

Methods   An independent medication guidance system was designed, and a medication guidance database was established by maintaining drug dictionary data and drug image information in the system. The patients’ visit information and prescription information were corresponded to the medication guidance database, and illustrated medication guidance content was provided for cardiovascular chronic disease patients, so as to achieve full coverage of individualized medication guidance for all patients in the hospital.

Results  2 286 kinds of drug dictionary data, 498 drug atlas data, and 570 cases of medication precautions were maintained in this system. The medication guidance database based on the information system can meet the needs of individualized medication guidance for patients. After implementation of the system, all discharged patients in the hospital could obtain a paper version of the medication guidance form. Outpatient patients and Internet consultation patients could receive medication guidance push through the hospital's WeChat public account, which reduced patients' waiting time for medication pickup and improved the efficiency of medication education. A total of 146 000 inpatients were provided with medication guidance, and a total of 123 000 outpatients and Internet patients were pushed with medication guidance content.

Conclusion  The application of the information system to achieve visual, multi-scene application of individualized medication guidance integrating drug verification and medication guidance improves the efficiency of pharmacists' medication instructions, ensures the safety of patients' medication, and provides references for innovating pharmaceutical service models and improving patients' medical experience.

1.中华人民共和国国务院. 中国防治慢性病中长期规划（2017—2025年）[J]. 中国实用乡村医生杂志, 2017, 24(11): 6-11. [The State Council of the People's Republic of China. National Medium and Long-term Plan on Prevention and Control of Noncommunicable Diseases (2017-2025)[J]. Chinese Practical Journal of Rural Doctor, 2017, 24(11): 6-11.] DOI: 10.3969/j.issn.1672-7185.2017.11.002.

2.中国共产党中央委员会, 中华人民共和国国务院. “健康中国2030”规划纲要[J]. 中国实用乡村医生杂志, 2017, 24(7): 1-12. [The Central Committee of the CPC, The State Council of the People's Republic of China. Health China 2030 Program[J]. Chinese Practical Journal of Rural Doctor, 2017, 24(7): 1-12.] https://d.wanfangdata.com.cn/periodical/zgsyxcyszz201707002.

3.关于加快药学服务高质量发展的意见[J]. 中华人民共和国国家卫生和计划生育委员会公报, 2018(11): 16-18. [Opinions on accelerating the development of high quality pharmaceutical care[J]. Gazette of the National Health and Family Planning Commission of People''s Republic of China, 2018, (11): 16-18.] https://www.cnki.com.cn/Article/CJFDTOTAL-WSGB201811006.htm.

4.中华人民共和国国家卫生健康委员会. 《关于印发加强医疗机构药事管理促进合理用药的意见的通知》政策解读[J]. 中国实用乡村医生杂志, 2020, 27(4): 1. [National Health Commission of the People's Republic of China. Policy interpretation of the Notice on Issuing Opinions on Strengthening Pharmaceutical Management in Medical Institutions and Promoting Rational Drug Use[J]. Chinese Practical Journal of Rural Doctor, 2020, 27(4): 1.] DOI: 10.3969/j.issn.1672 -7185.2020.04.002.

5.中华人民共和国国家卫生健康委员会. “十四五”国民健康规划[J]. 中国实用乡村医生杂志, 2022, 29(6): 1-11. [National Health Commission of the People's Republic of China. the National Health Plan of the 14 th Five-Year Plan[J]. Chinese Practical Journal of Rural Doctor, 2022, 29(6): 1-11.] DOI: 10.3969/j.issn.1672-7185.2022.06.001.

6.张逸舟, 都丽萍, 张宇晴, 等. 我国医疗机构用药教育开展现状调查[J]. 中国药房, 2024, 35(11): 1380-1385. [Zhang  YZ, Du LP, Zhang YQ, et al. Investigation on the current status of medication education in medical institutions in China[J]. Chiina Pharmacy, 2024, 35(11): 1380-1385.] DOI: 10.6039/j.issn.1001-0408.2024.11.17.

7.秦冰, 赵金红, 杜昕昱, 等. 我国三级公立医院合理用药指导开展情况与趋势分析[J]. 中国医院, 2023, 27(6): 26-29. [Qin B, Zhao JH, Du XY, et al. Analysis of the development and trends of rational medication guidance in China's Grade III public hospitals[J]. Chinese Hospitals, 2023, 27(6): 26-29.] DOI: 10.19660/j.issn.1671-0592.2023.06.07.

8.戚留英, 高悦. 冠心病患者对药物的认知及用药教育需求的调查分析[J]. 抗感染药学, 2021, 18(4): 580-583. [Qi LY, Gao  Y. Investigation and analysis on knowledge about drugs and notes of medication education in patients with coronary heart disease[J]. Anti Infect Pharm, 2021, 18(4): 580-583.] DOI: 10.13493/j.issn.1672-7878.2021.04-029.

9.郑珊珊, 李建涛, 许云晶, 等. 传统药学服务与“互联网 +药学服务”中的用药指导现状及患者需求分析[J]. 中国药学杂志, 2022, 57(11): 955-960. [Zheng SS, Li JT, Xu YJ, et al. Current situation of medication instruction and patients need analysis during pharmaceutical service between traditional model and "Internet Plus" model[J]. Chinese Pharmaceutical Journal, 2022, 57(11): 955-960.] DOI: 10.11669/cpj.2022.11.013.

10.程丽丹, 江一唱, 王天棋, 等. 心力衰竭患者全程化药学服务模式的建立与效果评估[J]. 中国药师, 2022, 25(2): 309-314. [Cheng LD, Jiang YC, Wang TQ, et al. Establishment and effect evaluation of whole-process pharmaceutical care model for patients with heart failure[J]. 2022, 25(2): 309-314.] DOI: 10.19962/j.cnki.issn1008-049X.2022.02.020.

11.陈新谦, 金有豫, 汤光, 主编. 陈新谦·新编药物学（第18版） [M]. 北京: 人民卫生出版社, 2018: 13-17.

12.穆煜, 张芸楠, 石秀锦, 等. 联合调脂治疗的指南、共识及相关研究进展[J]. 临床药物治疗杂志, 2020, 18(8): 10-13. [Mu Y, Zhang YN, Shi XJ, et al. Guidelines, concensus and research progress in combined lipid-modulating therapy[J]. Clinical Medication Journal, 2020, 18(8): 10-13.] DOI: 10.3969/j.issn.1672-3384.2020.08.003.

13.叶念, 李琴, 熊学惠. 我院抗血小板药物致不良反应的帕累托图分析[J]. 中南药学, 2020, 18(12): 2088-2092. [Ye N, Li  Q, Xiong XH. Pareto diagram of adverse drug reactions caused by antiplatelet drugs in our hospital[J]. Central South Pharmacy, 2020, 18(12): 2088-2092.] DOI: 10.7539/j.issn.1672-2981.2020.12.030.

14.成剑锋, 刘惠强, 黄洁, 等. 门诊药房用药教育现状及改善建议[J]. 中国医院药学杂志, 2023, 43(13): 1512-1515. [Cheng JF, Liu HQ, Huang J, et al. Status quo and improvement suggestions of medication education in outpatient pharmacy[J]. Chinese Journal of Hospital Pharmacy, 2023, 43(13): 1512-1515.] DOI: 10.13286/j.1001-5213.2023.13.17.

15.刘宏尉, 赵敏, 颜志文, 等. 应用患者教育系统开展个体化用药指导[J]. 中国医院药学杂志, 2023, 43(16): 1861-1865. [Liu HW, Zhao M, Yan ZW, et al. Using patient education system for individualized medication guidance[J]. Chinese Journal of Hospital Pharmacy, 2023, 43(16): 1861-1865.] DOI: 10.132 86/j.1001-5213.2023.16.16.

16.谢灵波, 郑子龙, 何莹, 等. 远程个体化用药教育系统构建 [J]. 中国药业, 2024, 33(11): 17-21. [Xie LB, Zheng ZL, He Y, et al. Construction of a remote personalized medication education system[J]. China Pharmaceuticals, 2024, 33(11): 17-21.] DOI: 10.3969/j.issn.1006-4931.2024.11.004.

17.马慧艳, 赵志刚, 乔春凤, 等. 中国城镇老年慢性病患者居家安全用药现状调查与影响因素分析: 一项基于全国多中心的研究[J]. 中南药学, 2024, 22(10): 2696-2701. [Ma HY, Zhao  ZG, Qiao CF, et a1. Survey of current status of home medication safety among elderly patients with chronic diseases in urban China: a nationwide multi-center study on influencing factors[J]. Central South Pharmacy, 2024, 22(10): 2696-2701.] DOI: 10.7539/j.issn.1672-2981.2024.10.023.